BX vs CNS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
BX
CNS
Investment Advisor Scores
CNS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BX | CNS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 21.5054 | 22.9358 | BX |
| PEG Ratio | 1.5257 | 2.0481 | BX |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 28.6% | 12.2% | BX |
| Earnings Growth | 57.3% | 31.9% | BX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 57.7/100 | 55.5/100 | BX |
| Profit Margin | 22.7% | 28.8% | CNS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BX
MarkupPrice above SMA50, rising 50-day trend (1.3% over 20 days), RSI 55
CNS
MarkupPrice above SMA50, rising 50-day trend (5.4% over 20 days), RSI 60
Fundamentals Snapshot
| Metric | BX | CNS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 17.1 | 21.2 |
| Trailing P/E | 29.0 | 25.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.1% |
| Gross Margin | 1.0% | 0.5% |
| Operating Margin | 0.5% | 0.3% |
| EPS | 4.42 | 3.25 |
| Dividend Yield | 0.04% | 0.03% |